# ImmunityBio, Inc.: Form 8-K, filed Aug 4, 2015

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2015-08-04
- Accepted by EDGAR: Aug 3, 2015, 21:15 ET
- Period: 2015-07-31
- Accession: 0001193125-15-275314
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312515275314/d158803d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312515275314/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312515275314/d158803d8k.htm

Filed Aug 4, 2015.
Source: SEC EDGAR, the filing index for accession 0001193125-15-275314. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
